Stewart WC - Search Results

1

The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension.

Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Smith SL, et al. Among authors: stewart wc. Acta Ophthalmol Scand. 1999 Apr;77(2):189-92. doi: 10.1034/j.1600-0420.1999.770214.x. Acta Ophthalmol Scand. 1999. PMID: 10321536 Free article. Clinical Trial.

2

Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma.

Konstas AG, Stewart WC, Stroman GA, Sine CS. Konstas AG, et al. Among authors: stewart wc. Ophthalmic Surg Lasers. 1997 Feb;28(2):111-7. Ophthalmic Surg Lasers. 1997. PMID: 9054481

3

The use of latanoprost 0.005% once daily and its effect on intraocular pressure as primary or adjunctive therapy.

Smith SL, Sine CS, Pruitt CA, Stewart WC. Smith SL, et al. Among authors: stewart wc. J Ocul Pharmacol Ther. 1999 Feb;15(1):29-39. doi: 10.1089/jop.1999.15.29. J Ocul Pharmacol Ther. 1999. PMID: 10048345 Clinical Trial.

4

Latanoprost 0.005% and anterior segment uveitis.

Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC. Smith SL, et al. Among authors: stewart wc. Acta Ophthalmol Scand. 1999 Dec;77(6):668-72. doi: 10.1034/j.1600-0420.1999.770612.x. Acta Ophthalmol Scand. 1999. PMID: 10634560 Free article.

5

Surgical vs medical management of chronic open-angle glaucoma.

Stewart WC, Sine CS, LoPresto C. Stewart WC, et al. Am J Ophthalmol. 1996 Dec;122(6):767-74. doi: 10.1016/s0002-9394(14)70372-1. Am J Ophthalmol. 1996. PMID: 8956630

6

The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily.

Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. Mundorf TK, et al. Among authors: stewart wc, stewart ja. J Ocul Pharmacol Ther. 1998 Apr;14(2):129-35. doi: 10.1089/jop.1998.14.129. J Ocul Pharmacol Ther. 1998. PMID: 9572538

7

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.

Stewart WC, Dubiner HB, Mundorf TK, Laibovitz RA, Sall KN, Katz LJ, Singh K, Shulman DG, Siegel LI, Hudgins AC, Nussbaum L, Apostolaros M. Stewart WC, et al. Am J Ophthalmol. 1999 Feb;127(2):142-7. doi: 10.1016/s0002-9394(98)00328-6. Am J Ophthalmol. 1999. PMID: 10030554 Clinical Trial.

8

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.

Konstas AG, Maltezos AC, Gandi S, Hudgins AC, Stewart WC. Konstas AG, et al. Among authors: stewart wc. Am J Ophthalmol. 1999 Jul;128(1):15-20. doi: 10.1016/s0002-9394(99)00073-2. Am J Ophthalmol. 1999. PMID: 10482089 Clinical Trial.

9

Daily cost of newer glaucoma agents.

Stewart WC, Hudgins AC, Pruitt CA, Sine C. Stewart WC, et al. J Ocul Pharmacol Ther. 1999 Oct;15(5):379-88. doi: 10.1089/jop.1999.15.379. J Ocul Pharmacol Ther. 1999. PMID: 10530699 Clinical Trial.

10

The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.

Konstas AG, Maltezos A, Mantziris DA, Sine CS, Stewart WC. Konstas AG, et al. Among authors: stewart wc. Eye (Lond). 1999 Jun;13 ( Pt 3a):314-8. doi: 10.1038/eye.1999.81. Eye (Lond). 1999. PMID: 10624424 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page